Moore’s Law may be out, but the future still holds laser-powered computers, open clinical trials, and a CRISPR-edited mouse in every lab
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Beckman Coulter Life Sciences launch FormaPure DNA at ASHG 2016, the newest addition to its growing portfolio of nucleic acid isolation
Seven Bridges Joins Cancer Moonshot Initiative with cloud platform to speed blood profiling research
Seven Bridges announces that its biomedical data analysis platform will be used by the Cancer Moonshot’s Blood Profiling Atlas project
Boston-based startup Veritas Genetics emerge from Series B funding round $30 million richer, to expand operations around the world
Analysis company Genomics plc appointed as Analysis Partner for the Genomics England Genomics Expert Network for Enterprises (GENE) Consortium
New course from the Wellcome Genome Campus aims to bridge the gap between academic innovation in genomics, and commercial success
Congenica’s role in developing genomic diagnostics has been recognised by the life sciences industry in the prestigious OBN Awards.